Statin Label Change May Signal Broader US FDA Shift On Drug Use During Pregnancy
Executive Summary
Agency is removing warning contraindicating use of statins during pregnancy; the move comes after FDA has permitted COVID-19 vaccination of pregnant women and amidst push for their enrollment in clinical trials.